한국어
English
日本語
中文(简体)
Bindakel Capsule 20 mg (Tafamidis Meglumine)
20mg
Prescription medication
Pfizer Korea Co., Ltd.
Tafamidis meglumine is a medication used for the treatment of transthyretin amyloidosis.
MFDS ingredient code M261964
Tafamidis meglumine is a drug that helps stabilize transthyretin protein and is used for the treatment of neurological disorders caused by amyloid deposition. This ingredient plays a role in protecting peripheral nerve function.
Tafamidis meglumine prevents transthyretin protein from abnormally misfolding and accumulating amyloid. This helps to prevent nerve damage and slow the progression of symptoms.
Approved uses differ by product. Check each product's information for its actual use.
Tafamidis meglumine acts by directly stabilizing transthyretin protein, distinguishing it from other neurological medications. It is particularly specialized as a treatment that targets amyloid deposition.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.